DK1549313T3 - Sammensætning og antiviral aktivitet hos substituerede azaindoloxoeddikesyre-piperazinderivater - Google Patents
Sammensætning og antiviral aktivitet hos substituerede azaindoloxoeddikesyre-piperazinderivaterInfo
- Publication number
- DK1549313T3 DK1549313T3 DK03784906.4T DK03784906T DK1549313T3 DK 1549313 T3 DK1549313 T3 DK 1549313T3 DK 03784906 T DK03784906 T DK 03784906T DK 1549313 T3 DK1549313 T3 DK 1549313T3
- Authority
- DK
- Denmark
- Prior art keywords
- composition
- antiviral activity
- piperazine derivatives
- oxoacetic acid
- acid piperazine
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- -1 azaindole oxoacetic acid piperazine derivatives Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/214,982 US20030207910A1 (en) | 2001-02-02 | 2002-08-07 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
PCT/US2003/024415 WO2004014380A1 (en) | 2002-08-07 | 2003-08-05 | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1549313T3 true DK1549313T3 (da) | 2012-10-01 |
Family
ID=31714265
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14164659.6T DK2801576T3 (da) | 2002-08-07 | 2003-08-05 | Sammensætning og antiviral aktivitet hos substituerede azaindoleoxoeddikepiperazinderivater |
DK12170639.4T DK2497770T3 (da) | 2002-08-07 | 2003-08-05 | Sammensætning og antiviral aktivitet hos substitueredeazaindoloxoeddikesyre-piperazinderivater |
DK03784906.4T DK1549313T3 (da) | 2002-08-07 | 2003-08-05 | Sammensætning og antiviral aktivitet hos substituerede azaindoloxoeddikesyre-piperazinderivater |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14164659.6T DK2801576T3 (da) | 2002-08-07 | 2003-08-05 | Sammensætning og antiviral aktivitet hos substituerede azaindoleoxoeddikepiperazinderivater |
DK12170639.4T DK2497770T3 (da) | 2002-08-07 | 2003-08-05 | Sammensætning og antiviral aktivitet hos substitueredeazaindoloxoeddikesyre-piperazinderivater |
Country Status (31)
Country | Link |
---|---|
US (1) | US20030207910A1 (da) |
EP (4) | EP2497770B1 (da) |
KR (1) | KR101045154B1 (da) |
CN (2) | CN100379421C (da) |
AR (1) | AR041190A1 (da) |
AU (2) | AU2003261367B2 (da) |
BR (1) | BRPI0313286B8 (da) |
CA (1) | CA2494832C (da) |
CY (3) | CY1113413T1 (da) |
DK (3) | DK2801576T3 (da) |
ES (4) | ES2481044T3 (da) |
GE (1) | GEP20084284B (da) |
HK (4) | HK1174037A1 (da) |
HR (1) | HRP20050123B8 (da) |
HU (1) | HUE027396T2 (da) |
IL (1) | IL166512A (da) |
IS (1) | IS2919B (da) |
MX (1) | MXPA05001441A (da) |
MY (1) | MY146549A (da) |
NO (1) | NO331591B1 (da) |
NZ (1) | NZ537930A (da) |
PE (1) | PE20040772A1 (da) |
PL (1) | PL219566B1 (da) |
PT (3) | PT2497770E (da) |
RS (1) | RS53428B (da) |
RU (1) | RU2325389C2 (da) |
SI (3) | SI2497770T1 (da) |
TW (1) | TWI328452B (da) |
UA (1) | UA82199C2 (da) |
WO (1) | WO2004014380A1 (da) |
ZA (1) | ZA200501018B (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307834D0 (en) * | 2003-04-04 | 2003-05-14 | Ta Contrast Ab | Composition |
US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
US20050124623A1 (en) * | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
US7776863B2 (en) * | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
US20050215544A1 (en) * | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
ATE412651T1 (de) | 2004-06-09 | 2008-11-15 | Glaxo Group Ltd | Pyrrolopyridinderivate |
US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
US7183284B2 (en) * | 2004-12-29 | 2007-02-27 | Bristol-Myers Squibb Company | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
US7601715B2 (en) | 2005-06-22 | 2009-10-13 | Bristol-Myers Squibb Company | Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
US7598380B2 (en) * | 2005-08-03 | 2009-10-06 | Bristol-Myers Squibb Company | Method of preparation of azaindole derivatives |
US7851476B2 (en) * | 2005-12-14 | 2010-12-14 | Bristol-Myers Squibb Company | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine |
US7807671B2 (en) * | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
US7504399B2 (en) * | 2006-06-08 | 2009-03-17 | Bristol-Meyers Squibb Company | Piperazine enamines as antiviral agents |
EP2046753A2 (en) * | 2006-07-06 | 2009-04-15 | Brystol-Myers Squibb Company | Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
WO2010036380A1 (en) | 2008-09-26 | 2010-04-01 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
GB0910667D0 (en) * | 2009-06-19 | 2009-08-05 | Glaxo Wellcome Mfg Pte Ltd | Novel compounds |
EP2601174B1 (en) * | 2010-08-06 | 2014-11-26 | Bristol-Myers Squibb Company | Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
WO2012075235A1 (en) * | 2010-12-02 | 2012-06-07 | Bristol-Myers Squibb Company | Alkyl amides as hiv attachment inhibitors |
CN102718692B (zh) * | 2012-07-03 | 2014-01-08 | 苏州和健医药科技有限公司 | 一种7位甲基-5位氧取代吲哚化合物的制备方法 |
AR101106A1 (es) | 2014-07-02 | 2016-11-23 | Pharmacyclics Llc | Inhibidores de tirosina quinasa de bruton |
WO2016044138A1 (en) * | 2014-09-17 | 2016-03-24 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
US10857140B2 (en) | 2015-05-06 | 2020-12-08 | The Regents Of The University Of California | K-Ras modulators |
JP2024519979A (ja) * | 2021-05-21 | 2024-05-21 | センター ナショナル デ ラ レシェルシェ サイエンティフィーク | 抗ウイルス剤としての新規アザインドール誘導体 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2761201A (en) | 1952-05-02 | 1956-09-04 | Griffin Wheel Co | Renewing molds |
US3830602A (en) | 1973-03-14 | 1974-08-20 | Commercial Shearing | Rotary pumps and motors |
US5023265A (en) * | 1990-06-01 | 1991-06-11 | Schering Corporation | Substituted 1-H-pyrrolopyridine-3-carboxamides |
IL99843A0 (en) | 1990-11-01 | 1992-08-18 | Merck & Co Inc | Synergistic combination of hiv reverse transcriptase inhibitors |
US5811432A (en) | 1990-11-09 | 1998-09-22 | Pfizer Inc | Azaoxindole derivatives |
WO1993001181A1 (en) | 1991-07-03 | 1993-01-21 | The Upjohn Company | Substituted indoles as anti-aids pharmaceuticals |
WO1993005020A1 (en) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
US5124327A (en) * | 1991-09-06 | 1992-06-23 | Merck & Co., Inc. | HIV reverse transcriptase |
US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
IT1265057B1 (it) | 1993-08-05 | 1996-10-28 | Dompe Spa | Tropil 7-azaindolil-3-carbossiamidi |
US5424329A (en) * | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
GB9420521D0 (en) | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
IL146309A0 (en) | 1999-05-21 | 2002-07-25 | Scios Inc | Indole-type derivatives as inhibitors of p38 kinase |
US6469006B1 (en) | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
US6476034B2 (en) | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
US20020061892A1 (en) | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
JP2004502768A (ja) | 2000-07-10 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | 置換インドールオキソアセチックピペラジン誘導体の組成物と抗ウイルス活性 |
US6403211B1 (en) | 2000-07-18 | 2002-06-11 | 3M Innovative Properties Company | Liquid crystal polymer for flexible circuits |
EP1363705B9 (en) * | 2001-02-02 | 2012-11-07 | Bristol-Myers Squibb Company | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
EP1476163A4 (en) * | 2002-02-23 | 2009-05-27 | Bristol Myers Squibb Co | METHOD FOR TREATING HIV INFECTION BY PREVENTING INTERACTION OF CD4 AND GP120 |
-
2002
- 2002-08-07 US US10/214,982 patent/US20030207910A1/en not_active Abandoned
-
2003
- 2003-05-08 UA UAA200502051A patent/UA82199C2/uk unknown
- 2003-08-04 MX MXPA05001441A patent/MXPA05001441A/es active IP Right Grant
- 2003-08-04 CN CNB038237431A patent/CN100379421C/zh not_active Expired - Lifetime
- 2003-08-04 RS YU20050108A patent/RS53428B/en unknown
- 2003-08-04 RU RU2005106350/04A patent/RU2325389C2/ru active
- 2003-08-04 NZ NZ537930A patent/NZ537930A/en not_active IP Right Cessation
- 2003-08-04 CN CN2008100099420A patent/CN101229164B/zh not_active Expired - Lifetime
- 2003-08-05 GE GEAP20038674A patent/GEP20084284B/en unknown
- 2003-08-05 SI SI200332361T patent/SI2497770T1/sl unknown
- 2003-08-05 KR KR1020057002158A patent/KR101045154B1/ko active IP Right Grant
- 2003-08-05 EP EP12170639.4A patent/EP2497770B1/en not_active Expired - Lifetime
- 2003-08-05 ES ES12170639.4T patent/ES2481044T3/es not_active Expired - Lifetime
- 2003-08-05 EP EP14164659.6A patent/EP2801576B1/en not_active Expired - Lifetime
- 2003-08-05 DK DK14164659.6T patent/DK2801576T3/da active
- 2003-08-05 SI SI200332464T patent/SI2801576T1/sl unknown
- 2003-08-05 TW TW092121422A patent/TWI328452B/zh not_active IP Right Cessation
- 2003-08-05 SI SI200332192T patent/SI1549313T1/sl unknown
- 2003-08-05 AU AU2003261367A patent/AU2003261367B2/en not_active Ceased
- 2003-08-05 CA CA2494832A patent/CA2494832C/en not_active Expired - Lifetime
- 2003-08-05 DK DK12170639.4T patent/DK2497770T3/da active
- 2003-08-05 ES ES03784906T patent/ES2388919T3/es not_active Expired - Lifetime
- 2003-08-05 HU HUE14164659A patent/HUE027396T2/en unknown
- 2003-08-05 EP EP15180409.3A patent/EP2975038B1/en not_active Expired - Lifetime
- 2003-08-05 PT PT121706394T patent/PT2497770E/pt unknown
- 2003-08-05 PT PT03784906T patent/PT1549313E/pt unknown
- 2003-08-05 EP EP03784906A patent/EP1549313B9/en not_active Expired - Lifetime
- 2003-08-05 BR BRPI0313286A patent/BRPI0313286B8/pt not_active IP Right Cessation
- 2003-08-05 DK DK03784906.4T patent/DK1549313T3/da active
- 2003-08-05 WO PCT/US2003/024415 patent/WO2004014380A1/en active Search and Examination
- 2003-08-05 PT PT141646596T patent/PT2801576E/pt unknown
- 2003-08-05 ES ES15180409.3T patent/ES2641893T3/es not_active Expired - Lifetime
- 2003-08-05 PL PL375360A patent/PL219566B1/pl unknown
- 2003-08-05 ES ES14164659.6T patent/ES2560844T3/es not_active Expired - Lifetime
- 2003-08-07 MY MYPI20033007A patent/MY146549A/en unknown
- 2003-08-07 PE PE2003000789A patent/PE20040772A1/es active IP Right Grant
- 2003-08-07 AR ARP030102835A patent/AR041190A1/es active IP Right Grant
-
2005
- 2005-01-26 IL IL166512A patent/IL166512A/en active IP Right Grant
- 2005-01-28 NO NO20050514A patent/NO331591B1/no not_active IP Right Cessation
- 2005-02-01 IS IS7682A patent/IS2919B/is unknown
- 2005-02-03 ZA ZA200501018A patent/ZA200501018B/en unknown
- 2005-02-07 HR HRP20050123AA patent/HRP20050123B8/hr not_active IP Right Cessation
- 2005-07-27 HK HK13101431.0A patent/HK1174037A1/xx not_active IP Right Cessation
- 2005-07-27 HK HK05106424.8A patent/HK1072731A1/xx not_active IP Right Cessation
-
2009
- 2009-06-12 AU AU2009202361A patent/AU2009202361B2/en not_active Ceased
-
2012
- 2012-08-21 CY CY20121100745T patent/CY1113413T1/el unknown
-
2014
- 2014-07-31 CY CY20141100578T patent/CY1115580T1/el unknown
-
2015
- 2015-03-23 HK HK15102916.0A patent/HK1202530A1/xx not_active IP Right Cessation
-
2016
- 2016-02-26 CY CY20161100162T patent/CY1117217T1/el unknown
- 2016-07-12 HK HK16108137.9A patent/HK1220181A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1549313T3 (da) | Sammensætning og antiviral aktivitet hos substituerede azaindoloxoeddikesyre-piperazinderivater | |
IS2912B (is) | Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna | |
NO20054969D0 (no) | 2-cyanopropansyreamid- og esterderivater og deres anvendelse | |
ATE353882T1 (de) | Heteroarylalkyl piperazinederivate als partielle inhibitoren der fettsäureoxidation | |
DK1373224T3 (da) | Nye spirotricykliske derivater og deres anvendelse som phosphodiesterase 7 inhibitorer | |
NO2014005I1 (no) | olodaterol, syreaddisjonssalter og farmakologisk akseptable syrer derav | |
DK1208086T3 (da) | Benzamidformulering med histondeacetylaseinhibitoraktivitet | |
DK1578755T3 (da) | Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse | |
PT1296981E (pt) | Derivados substituidos da pirrolopiridinona uteis como inibidores da fosfodiesterase | |
NO20043508L (no) | Pyrrolopyrimidin og pyrrolopyridinderivater substituert med syklisk aminogruppe | |
HK1082173A1 (en) | Generalized metronome for modification of biorhythmic activity | |
ITMI20021247A1 (it) | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche | |
NO20051617D0 (no) | Piperidinderivater av heterocyklusfusjonerte benzodioksaner med antidepressiv aktivitet | |
NO20022007L (no) | Krystaller av et oksyiminoalkansyrederivat og deres anvendelse som antidiabetika | |
IL163959A (en) | Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them | |
SE0302129L (sv) | Farmaceutiska kompositioner med antibiotisk aktivitet | |
DE10297810D2 (de) | Fussboden aus einzelnen Elementen | |
DK1509085T3 (da) | Phosphonater og derivater heraf som fremmere af insekticiders aktivitet | |
EE200100537A (et) | Maduuraftalasiini derivaatide kasutamine proinflammatoorsete tsütokiinide inhibiitoritena | |
AU2003231527A8 (en) | Novel derivatives of carnosic acid | |
SI1363705T1 (sl) | Sestavek in antivirusna aktivnost substituiranih azaindoleoksoocetnih piperazinskih derivatov | |
PL369675A1 (en) | Use of n-(indolcarbonyl-)piperazine derivatives | |
ITMI20021455A0 (it) | Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico | |
IL166523A (en) | Matrons are built to match biological rhythmic activity | |
SE0202986D0 (sv) | Naphthamide derivatives and their use |